North America
FDA Wants To Improve Risk-Based Monitoring In Clinical Trials
RBM is essential in clinical trials, where sponsors monitor clinical investigations and determine any problems or risks involved with their studies that could impact participants or the general public. The FDA wants to improve this monitoring system to make it quicker...
